Skip to main content

Advertisement

SpringerLink
Log in

Validation of the Chinese Version of the Cognitive Symptom Checklist-Work-21 in Breast Cancer Survivors

  • Published:
Journal of Occupational Rehabilitation Aims and scope Submit manuscript

Abstract

Purpose The purpose of this study was to translate the Cognitive Symptom Checklist-Work-21 (CSC-W21), into Chinese, and culturally adapt and validate the Chinese version, a measure of work-related cognitive limitations in occupationally active breast cancer survivors (BCS). Methods The translation of the English version of the CSC-W21 followed a systematic procedure. Exploratory factor analysis was used to identify factor structures. The internal consistency of the factors was assessed by calculating the Cronbach’s alpha reliability coefficients. Item- and scale-level content validity was determined. The intra-class correlation coefficient (ICC) was used to analyze test–retest reliability. A total of two hundred and twenty BCS participated in the psychometric testing of the CSC-W21-C. The construct validity of the total score of the CSC-W21-C was determined through convergent validity and an analysis of its relationship with the four subscales of the Work Limitations Questionnaire (WLQ), a measure of four types of job task difficulties. Results The CSC-W21-C demonstrated item- and scale-level content validity (>.80). The factor structure of the CSC-W21-C was similar to the original English version. The internal consistency of the subscales of the CSC-W21-C ranged from .84 to .95. The ICC was between .80 and .96 indicating good test–retest reliability. The CSC-W21-C was significantly correlated with the WLQ, particularly the mental-interpersonal subscale, where it accounted for 27.3 % of the total variance. Conclusions The findings indicate that the CSC-W21-C has sound measurement properties that strongly suggest it can be used in future assessment and intervention research to identify cognitive limitations related to specific work tasks in BCS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Fantoni SQ, Peugniez C, Duhamel A, Skrzypczak J, Frimat P, Leroyer A. Factors related to return to work by women with breast cancer in Northern France. J Occup Rehabil. 2010;20:49–58.

    Article  PubMed  Google Scholar 

  3. Linos E, Spanos D, Rosner BA, Linos K, Hesketh T, Qu JD, et al. Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst. 2008;100(19):1352–60.

    Article  PubMed Central  PubMed  Google Scholar 

  4. China National Cancer Institute. 2012 Annual Oncology Report. Ministry of Health, Bureau of Disease Prevention, Beijing.

  5. Roelen CA, Koopmans PC, van Rhenen W, Groothoff JW, van der Klink JJ, Bültmann U. Trends in return to work of breast cancer survivors. Breast Cancer Res Treat. 2011;128(1):237–42.

    Article  CAS  PubMed  Google Scholar 

  6. US National Cancer Institute. The SEER cancer statistics review, 1975–2010. Bethesda, MD. http://seer.cancer.gov/csr/1975_2010/results_merged/topic_survival_by_yeardx.pdf. Accessed 15 April 2014.

  7. Liu S, Zhao J, Liu J, Sun ZP, Hua YQ, Lu DM, et al. Effects of mastectomy on the 5-year recurrence rate in breast cancer patients. J Chin Integr Med. 2008;6(10):1000–4 [in Chinese].

    Article  Google Scholar 

  8. Bouknight RR, Bradley CJ, Luo Z. Correlates of return to work for breast cancer survivors. J Clin Oncol. 2006;24:345–53.

    Article  PubMed  Google Scholar 

  9. Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat. 2009;116(1):113–23.

    Article  PubMed  Google Scholar 

  10. Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Hanscom BS, et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat. 2008;110(1):143–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006;20:76–89.

    Article  PubMed  Google Scholar 

  12. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005;59:60–70.

    Article  PubMed  Google Scholar 

  13. Von Ah D, Harvison KW, Monahan PO, Moser LR, Zhao Q, Carpenter JS, et al. Cognitive function in breast cancer survivors compared to healthy age- and education-matched women. Clin Neuropsychol. 2009;23(4):661–74.

    Article  Google Scholar 

  14. Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2- year follow-up of a prospective controlled study. J Clin Oncol. 2005;23(31):8025–32.

    Article  PubMed  Google Scholar 

  15. Bender CM, Pacella ML, Sereika SM, Brufsky AM, Vogel VG, Rastogi P, et al. What do perceived cognitive problems reflect? J Support Oncol. 2008;6(5):238–42.

    PubMed Central  PubMed  Google Scholar 

  16. Palmer J, Trotter T, Joy A, Carlson L. Cognitive effects of tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. J Cancer Surviv. 2008;2(4):275–82.

    Article  PubMed  Google Scholar 

  17. Eberling J, Wu C, Tong-Turnbeaugh R, Jagust W. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage. 2004;21(1):364–71.

    Article  PubMed  Google Scholar 

  18. Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld LD. Hormonal therapies for early breast cancer: systematic review and economic evaluation. Health Technol Assess. 2007;11(26):iii–iv, ix–xi, 1–134.

  19. Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause. 2007;14(6):995–8.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292–9.

    Article  CAS  PubMed  Google Scholar 

  21. Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer. 2004;91:822–8.

    PubMed Central  CAS  PubMed  Google Scholar 

  22. Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15:306–20.

    Article  PubMed  Google Scholar 

  23. Gandubert C, Carrière I, Escot C, Soulier M, Hermès A, Boulet P, et al. Onset and relapse of psychiatric disorders following early breast cancer: a case–control study. Psychooncology. 2009;18:1029–37.

    Article  PubMed  Google Scholar 

  24. Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology. 2004;13(1):61–6.

    Article  PubMed  Google Scholar 

  25. Hansen JA, Feuerstein M, Calvio LC, Olsen CH. Breast cancer survivors at work. J Occup Environ Med. 2008;50(7):777–84.

    Article  PubMed  Google Scholar 

  26. de Boer AGEM. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342–7.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Mehnert A. Employment and work related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77:109–30.

    Article  PubMed  Google Scholar 

  28. Amir Z, Neary D, Luker K. Cancer survivors’ views of work 3 years post diagnosis: a UK perspective. Eur J Oncol Nurs. 2008;12:190–7.

    Article  PubMed  Google Scholar 

  29. Balak F, Roelen CA, Koopmans PC, ten Berge EE, Groothoff JW. Return to work after early-stage breast cancer: a cohort study into the effects of treatment and cancer-related symptoms. J Occup Rehabil. 2008;18:267–72.

    Article  PubMed  Google Scholar 

  30. Pryce J. Cancer survivorship and work: symptoms, supervisor response, co-worker disclosure and work adjustment. J Occup Rehabil. 2007;17(1):83–92.

    Article  PubMed  Google Scholar 

  31. Spelten E, Verbeek J, Uitterhoeve AL, Ansink AC, van der Lelie J, de Reijke TM, et al. Cancer, fatigue and the return of patients to work—a prospective cohort study. Eur J Cancer. 2003;39:1562–7.

    Article  CAS  PubMed  Google Scholar 

  32. Wagner L, Sweet J, Butt Z, Lai J, Cella D. Measuring patient self reported cognitive function: development of the Functional Assessment of Cancer Therapy-Cognitive Function Instrument. J Support Oncol. 2009;7:W32–9.

    Google Scholar 

  33. Breckenridge LM, Bruns GL, Todd BL, Feuerstein M. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors. Psychooncology. 2012;21(1):43–53.

    Article  PubMed  Google Scholar 

  34. Ottati A, Feuerstein M. Brief self-report measure of work-related cognitive limitations in breast cancer survivors. J Cancer Surviv. 2013;7:262–73.

    Article  PubMed  Google Scholar 

  35. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417–32.

    Article  CAS  PubMed  Google Scholar 

  36. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–91.

    Article  CAS  PubMed  Google Scholar 

  37. Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30:459–67.

    Article  PubMed  Google Scholar 

  38. Portney LG, Watkins MP. Foundations of Clinical Research: Application to Practice. 3rd ed. London: Prentice-Hall; 2009.

    Google Scholar 

  39. Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52(2):219–27.

    Article  PubMed  Google Scholar 

  40. Feuerstein M, Hansen JA, Calvio LC, Johnson L, Ronquillo JG. Work productivity in brain tumor survivors. J Occup Environ Med. 2007;49:803–11.

    Article  PubMed  Google Scholar 

  41. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance Systems Survey Questionnaire: US Department of Health and Human Services. Atlanta, GA: Centers for Disease Control and Prevention; 1999.

  42. Lerner D, Amick BC III, Rogers WH, Malspeis S, Bungay K, Cynn D. The Work Limitations Questionnaire. Med Care. 2001;39:72–85.

    Article  CAS  PubMed  Google Scholar 

  43. Tamminga SJ, Verbeek J, Frings-Dresen M, Boer A. Measurement properties of the Work Limitations Questionnaire were sufficient among cancer survivors. Qual Life Res. 2014;23:515–25.

    Article  PubMed  Google Scholar 

  44. Bjelland I, Dahl A, Haug T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77. doi:10.1016/S0022-3999(01)00296-3.

    Article  PubMed  Google Scholar 

  45. Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G. Screening for depression in head and neck cancer. Psychooncology. 2004;13:269–80.

    Article  PubMed  Google Scholar 

  46. Alexander S, Palmer C, Stone PC. Evaluation of screening instruments for depression and anxiety in breast cancer survivors. Breast Cancer Res Treat. 2010;122(2):573–8.

    Article  PubMed  Google Scholar 

  47. Leung CM, Ho S, Kan CS. Evaluation of the Chinese version of the hospital anxiety and depression scale: a cross-cultural perspective. Int J Psychosom. 1993;40:29–34.

    CAS  PubMed  Google Scholar 

  48. Huang H, Zhang J, Deng XM, Xu L. Application status of psychological rating scales for patients with cancer. Nurs J Chin PLA. 2006;23(5):59–62 (in Chinese).

    CAS  Google Scholar 

  49. Zhang W, Wang W, Hong J, Chen Y. Research on critical value of Hospital Anxiety and Depression Scale in screening anxiety and depression of hospitalized cancer patients. Chin J Nurs. 2012;19:1–4 (in Chinese).

    Google Scholar 

  50. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.

    CAS  PubMed  Google Scholar 

  51. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.

    Article  CAS  PubMed  Google Scholar 

  52. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.

    Article  CAS  PubMed  Google Scholar 

  53. Zhao H, Kanda K. Testing psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQC30). J Epidemiol. 2004;14(6):193–203.

    Article  PubMed  Google Scholar 

  54. Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs. 2007;11(1):6–15.

    Article  PubMed  Google Scholar 

  55. Biglia N, Bounous VE, Malabaila A, Palmisano D, Torta DM, D’Alonzo M, et al. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care (Engl). 2012;21(4):485–92.

    Article  CAS  Google Scholar 

  56. Munir F, Kalawsky K, Lawrence C, Yarker J, Haslam C, Ahmed S. Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: a needs analysis. Cancer Nurs. 2011;34(5):385–92.

    Article  PubMed  Google Scholar 

  57. Todd BL, Feuerstein EL, Feuerstein M. When breast cancer survivors report cognitive problems at work. Int J Psychiatry Med. 2011;42(3):279–94.

    Article  PubMed  Google Scholar 

  58. Chan RCK, Shum D, Toulopoulou T, Chen EYH. Assessment of executive functions: review of instruments and identification of critical issues. Arch Clin Neuropsychol. 2008;23(2):201–16.

    Article  PubMed  Google Scholar 

  59. Feuerstein M, Hansen JA, Calvio LC, Johnson L, Ronquillo JG. Work productivity in brain tumor survivors. J Occup Environ Med. 2007;49(7):803–11.

    Article  PubMed  Google Scholar 

  60. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995.

    Google Scholar 

  61. Feuerstein M, Todd BL, Moskowitz MC, Bruns GL, Stoler MR, Nassif T, et al. Work in cancer survivors: a model for practice and research. J Cancer Surviv. 2010;4(4):415–37.

    Article  PubMed  Google Scholar 

  62. Maunsell E, Drolet M, Brisson J, Brisson C, Mâsse B, Deschênes L. Work situation after breast cancer: results from a population-based study. J Natl Cancer Inst. 2004;96:1813–21.

    Article  PubMed  Google Scholar 

  63. Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care. 2007;16:17–25.

    Article  CAS  Google Scholar 

  64. Netherlands Society of Occupational Medicine. Cancer and Work (in Dutch). http://nvab.artsennet.nl/Artikel-3/Blauw druk-Kanker-en-Werk.htm. Accessed 15 April 2014.

  65. Gonzalez-Calvo J, Gonzalez VM, Lorig K. Cultural diversity issues in the development of valid and reliable measures of health status. Arthritis Care Res. 1997;10:448–56.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong

    Andy S. K. Cheng

  2. Department of Obstetrics, The Third Affiliated Hospital of Guangzhou Medical University, No. 63 DouBao Road, Liwan District, Guangzhou, 510150, China

    Yingchun Zeng

  3. Departments of Medical and Clinical Psychology and Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    Michael Feuerstein

Authors
  1. Andy S. K. Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yingchun Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Feuerstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andy S. K. Cheng.

Additional information

The opinions and assertions contained herein are the private views of the authors and are not to be construed as being official or as reflecting the views of the Uniformed Services University of the Health Sciences or the Department of Defense.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, A.S.K., Zeng, Y. & Feuerstein, M. Validation of the Chinese Version of the Cognitive Symptom Checklist-Work-21 in Breast Cancer Survivors. J Occup Rehabil 25, 685–695 (2015). https://doi.org/10.1007/s10926-015-9576-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10926-015-9576-3

Keywords

Search

Navigation